Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of markers in the identification of cardiotoxic agents and in the diagnosis and monitoring of cardiomyopathy and cardiovascular disease

Use of markers in the identification of cardiotoxic agents and in the diagnosis and monitoring of cardiomyopathy and cardiovascular disease

US Patent 10352947 · Granted Jul 16, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Interrogatory cell-based assays and uses thereof2025
Interrogatory cell-based assays and uses thereof2025
Interrogatory cell-based assays and uses thereof2025
Biomarkers for efficacy of prophylactic treatments against stress-induced affect2025
Markers for the diagnosis of biochemical recurrence in prostate cancer2025
Markers for the diagnosis of biochemical recurrence in prostate cancer2025
Markers for the diagnosis of biochemical recurrence in prostate cancer2025
Methods of treatment of temozolomide-resistant glioma using coenzyme Q102025
Methods of treatment of temozolomide-resistant glioma using coenzyme Q102025
Methods of treatment of temozolomide-resistant glioma using coenzyme Q102025
Methods for treatment of oncological disorders using an epimetabolic shifter (co2025
Bayesian causal relationship network models for healthcare diagnosis and treatme2023